MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059964 A) filed by Noida Institute Of Engineering And on May 12, 2026, for An Oral Fixed Dose Combination Formulation.
Inventors include Dr. Anjna Rani; and Archna Singh.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: An oral fixed dose combination formulation is disclosed comprising a first active phase, a second active phase, a functional separation region, a release-modulating layer, a protective outer coating, and a disintegration support matrix arranged within a final oral dosage unit body. The formulation permits active-specific excipient environments, reduces direct incompatibility, and supports immediate, delayed, sustained, or sequential release. The dosage unit may be configured as a tablet, capsule, multiparticulate assembly, or coated oral unit suitable for stable and reproducible administration.
Disclaimer: Curated by HT Syndication.
